PANEL PROGRAM
PN01 - Challenges And
Development Pathways Of Digital Health Technology Assessment: Perspectives From
Low- And Middle-Income Countries
PN02 - Greenlight Or Redline:
Health Technology Assessment Across The Artificial Intelligence Lifecycle
Track: Evidence Retrieval & Synthesis
PN03 - Health Economics Methods Advisory (HEMA)
PN05 HTAfrica Network At HTAi: Regional Bridges For Economic Stability, Strenghtening Equity, And Sustainability Of Healthcare In Africa
PN06 - Legislation For Rare Diseases Driving Change In HTA
PN07 - Reflections From The 2026 HTAi Global Policy Forum: Health Technology Assessment Under Pressure And The Health Technology Trilemma
PN08 - Rethinking Fairness In Health Technology Assessment: Addressing Equity Gaps In Topic Selection For Orphan Drugs
PN09 - A Roadmap For Value Frameworks In Transitioning Economies: Opportunity Cost Vs. Political Reality
PN11 - From Evidence To System Shaping: Adaptive HTA, Methodological Guardrails And Capacity-Building From South–South Collaboration
PN12 - Mapping Health Technology Assessment Training Needs In Low- and Middle-Income Countries: Challenges And Opportunities
Track: Capacity Building In HTA
PN13 - Navigating Health Technology Assessment In Small Countries: Challenges, Innovations, And Collaborative Pathways
PN14 - Seven Urgent Actions To Elevate Patient Involvement For Relevant And Sustainable Health Technology Assessment
PN15 - System Shaping With Patients: Building Cost-Effectiveness Evidence For Lp(a) Screening With FH Europe
PN16 - The Role Of HTA In Driving The Digital Health Transition In Europe. The Case Of The EDiHTA Project
PN17 - AI Transforming Evidence Generation For HTA
PN18 - Equity In HTA: Regional Experiences And Approaches To Measuring Impact
Track: Equity In HTA
PN19 - From Data To Decisions: Strengthening HTA Literacy And Statistical Capacity For Future-Ready Health Systems
PN20 - Improving Patient Involvement In Health Technology Assessments From Goal Setting To Evalution
PN21 - Interventions To Reach Zero-Dose Children In Sub-Saharan Africa: What Works And What Doesn't - Experiences From Kenya Nigeria, And Rwanda
PN22 - The Role Of HTA In The Current Era
PN23 - Beyond the Health System: Should the Societal Perspective Be Included in HTA?
PN24 - Values, Outcomes And Impact Of Health Technology Assessment Agencies: System Shapers For Resilient, Inclusive And Future-Ready Health Systems
PN25 - Beyond The Guidelines: Uncovering Hidden Realities Of Procedural And Organizational Health Technology Assessment Practices
PN26 - From Evidence To Impact: Leveraging Health Technology Assessment To Shape Pluralistic Health Systems In India And Brazil
Track: Implementing HTA Programs
PN37 - Lessons Learned From The First Joint Clinical Assessments: Relevance For National HTA In The EU And Beyond
PN28 - Helping Or Hurting Health Technology Assessments? When Is Transportability An Appropriate Solution When Local Real-World Evidence Is Limited?
PN29 - How Can Artificial Intelligence Health Technologies Be Scientifically Evaluated? Health Technology Assessment Perspective From Selected Countries
PN30 - Integrating Equity into Health Technology Assessment: Lessons from the Latin America Policy Forum
Track: Policy & Impact Of HTA
PN31 - Towards A Sustainable Dialogue Between HTA Bodies And Academia: The SUSTAIN-DIALOGUE Initiative
PN32 - Women’s Health And Equity Frameworks: The Potential Of HTA For Gender-Transformative Health Systems
PN33 - Dialogues On AI In Health Technology Assessment: Opportunities For Innovation And Collaboration
PN34 - From EvaluationTo Stewardship: The Role Of HTA In Advancing Environmentally Sustainable Digital Health Systems
Track: Environmental Sustainability In HTA
PN35 - Health Technology Assessment In China: Enabling Patient Access Through Evolving Reimbursement And Policy Processes
PN36 - Horizon Scanning (HS) To Aid System Shaping: Perspectives From Asia-Pacific Region (Australia, Malaysia, Singapore, Hong Kong)
PN04 - Highlights From IJTAHC On Patient And Stakeholder Engagement As A Drive For Shaping Health Systems
PN38 - Operationalizing Patient Involvement In HTA In Low-Resource Settings: Challenges And Strategies
Track: Implementing HTA Programs
PN39 - Promoting Health Technology Assessment As Driver For Sustainable Access To Healthcare In Low Resource And Volatile Policy Settings
PN40 - Strengthening Deliberative Processes For Rare Disease Health Technology Assessment In Data-Limited Contexts
HTAi 2026 ANNUAL MEETING
© Copyright 2025 HTAi